Clinical Trial

Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit

Foghorn to host a virtual investor event on updates for its Selective ARID1B, Selective CBP and Selective EP300 degrader programs…

2 months ago

MOEA DoIT Showcases 65 Cutting-Edge Technologies at TIE

Unveiling AI Clothing Sorting System and New Equipment for Depression Treatment TAIPEI, Oct. 16, 2025 /PRNewswire/ -- The Department of…

2 months ago

C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub

AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease…

2 months ago

The Lustgarten Foundation Gathered Nation’s Foremost Pancreatic Cancer Experts for Annual Scientific Advisory Board Meeting

COLD SPRING HARBOR, N.Y., Oct. 15, 2025 /PRNewswire/ -- The Lustgarten Foundation, the world's largest private funder of pancreatic cancer…

2 months ago

Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into how ICON Strategic Solutions (ISS) delivers Functional Service Provider (FSP) services that outperform…

2 months ago

Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's…

2 months ago

AccessHope Launches New Service to Help More Cancer Patients Enroll in Clinical Trials

Expands support and access by matching eligible patients to trials and guiding them through enrollment DUARTE, Calif., Oct. 15, 2025 /PRNewswire/…

2 months ago

TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top…

2 months ago

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to…

2 months ago